Search research articles
Contact Us
Filters
Showing results (81-90 of 158) with videos related to
Page
of 16
Sort By:
Medizinische Monatsschrift Fur Pharmazeuten
|
November 6, 2004
[Treatment of patients with intestinal cancer. Increased neurotoxicity after oxaliplatin and related liver metastasis]
Annette Junker, Albrecht Kretzschmar, Ulrike Böhm, et al.
Chemico-Biological Interactions
|
February 17, 2010
ATP sensitizes H460 lung carcinoma cells to cisplatin-induced apoptosis
Els L R Swennen, Vanessa Ummels, Irina Buss, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 11, 2017
Semimechanistic Bone Marrow Exhaustion Pharmacokinetic/Pharmacodynamic Model for Chemotherapy-Induced Cumulative Neutropenia
Andrea Henrich, Markus Joerger, Stefanie Kraff, et al.
Scientific Reports
|
April 8, 2026
Development of a questionnaire to assess the medication literacy of patients receiving oral anticancer drugs
Wolfgang Fehrmann, Anna Katharina Moritz, Vanessa Basten, et al.
International Journal of Clinical Pharmacy
|
October 30, 2015
Analysis of drug-related problems in three departments of a German University hospital
Rebekka Lenssen, Axel Heidenreich, Jörg B Schulz, et al.
Clinical Pharmacokinetics
|
October 9, 2008
Pharmacokinetic/pharmacodynamic modelling of venlafaxine: pupillary light reflex as a test system for noradrenergic effects
Andreas Lindauer, Timo Siepmann, Reinhard Oertel, et al.
European Journal of Clinical Pharmacology
|
October 22, 2002
Effect of grapefruit juice intake on etoposide bioavailability
Stefanie Reif, Marianne C Nicolson, Donald Bisset, et al.
Journal of Geriatric Oncology
|
January 14, 2020
Comparing the performance of the CARG and the CRASH score for predicting toxicity in older patients with cancer
Imke Ortland, Monique Mendel Ott, Michael Kowar, et al.
BMC Geriatrics
|
August 30, 2022
Medication risks in older patients (70 +) with cancer and their association with therapy-related toxicity
Imke Ortland, Monique Mendel Ott, Michael Kowar, et al.
Clinical Pharmacokinetics
|
August 11, 2011
Clinical pharmacokinetics of tyrosine kinase inhibitors: focus on pyrimidines, pyridines and pyrroles
Paola Di Gion, Friederike Kanefendt, Andreas Lindauer, et al.
Page
of 16
Search research articles
Search
Showing results (81-90 of 158) with videos related to
Sort By:
Page
of 16
Medizinische Monatsschrift Fur Pharmazeuten
|
November 6, 2004
[Treatment of patients with intestinal cancer. Increased neurotoxicity after oxaliplatin and related liver metastasis]
Annette Junker, Albrecht Kretzschmar, Ulrike Böhm, et al.
Chemico-Biological Interactions
|
February 17, 2010
ATP sensitizes H460 lung carcinoma cells to cisplatin-induced apoptosis
Els L R Swennen, Vanessa Ummels, Irina Buss, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 11, 2017
Semimechanistic Bone Marrow Exhaustion Pharmacokinetic/Pharmacodynamic Model for Chemotherapy-Induced Cumulative Neutropenia
Andrea Henrich, Markus Joerger, Stefanie Kraff, et al.
Scientific Reports
|
April 8, 2026
Development of a questionnaire to assess the medication literacy of patients receiving oral anticancer drugs
Wolfgang Fehrmann, Anna Katharina Moritz, Vanessa Basten, et al.
International Journal of Clinical Pharmacy
|
October 30, 2015
Analysis of drug-related problems in three departments of a German University hospital
Rebekka Lenssen, Axel Heidenreich, Jörg B Schulz, et al.
Clinical Pharmacokinetics
|
October 9, 2008
Pharmacokinetic/pharmacodynamic modelling of venlafaxine: pupillary light reflex as a test system for noradrenergic effects
Andreas Lindauer, Timo Siepmann, Reinhard Oertel, et al.
European Journal of Clinical Pharmacology
|
October 22, 2002
Effect of grapefruit juice intake on etoposide bioavailability
Stefanie Reif, Marianne C Nicolson, Donald Bisset, et al.
Journal of Geriatric Oncology
|
January 14, 2020
Comparing the performance of the CARG and the CRASH score for predicting toxicity in older patients with cancer
Imke Ortland, Monique Mendel Ott, Michael Kowar, et al.
BMC Geriatrics
|
August 30, 2022
Medication risks in older patients (70 +) with cancer and their association with therapy-related toxicity
Imke Ortland, Monique Mendel Ott, Michael Kowar, et al.
Clinical Pharmacokinetics
|
August 11, 2011
Clinical pharmacokinetics of tyrosine kinase inhibitors: focus on pyrimidines, pyridines and pyrroles
Paola Di Gion, Friederike Kanefendt, Andreas Lindauer, et al.
Page
of 16